← Back to Search

Omega-3 Fatty Acid Supplement

EPA + DHA Ruby-O for Bioavailability

N/A
Waitlist Available
Research Sponsored by Midwest Center for Metabolic and Cardiovascular Research
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 24 hours
Awards & highlights

Study Summary

This trial will compare the absorption of EPA and DHA from two different supplements in healthy adults.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 24 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 24 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Baseline-adjusted geometric mean ratio for EPA + DHA AUC
Secondary outcome measures
Baseline-adjusted AUC for EPA and DHA
Baseline-adjusted maximum concentration for EPA, DHA, and EPA + DHA
Baseline-adjusted, dose-normalized AUC for EPA, DHA, and EPA + DHA
+4 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: EPA + DHA Ruby-OExperimental Treatment1 Intervention
Subject will receive a single 1000 mg oral dose of EPA + DHA Ruby-O capsule
Group II: EPA + DHA Krill OilActive Control1 Intervention
Subject will receive a single 1000 mg oral dose of EPA + DHA krill oil capsule
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
EPA + DHA Ruby-O
2022
N/A
~30

Find a Location

Who is running the clinical trial?

Midwest Center for Metabolic and Cardiovascular ResearchLead Sponsor
20 Previous Clinical Trials
824 Total Patients Enrolled
2 Trials studying Bioavailability
48 Patients Enrolled for Bioavailability
NaturmegaUNKNOWN
Kevin C Maki, PhDStudy DirectorMB Clinical Research & Consulting
16 Previous Clinical Trials
936 Total Patients Enrolled
2 Trials studying Bioavailability
48 Patients Enrolled for Bioavailability

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~10 spots leftby Apr 2025